Section Arrow
Quote
LMAT.NASDAQ
- LeMaitre Vascular
Quotes are at least 15-min delayed:2025/07/06 06:25 EDT
Last
 84.39
+0.545 (+0.65%)
Day High 
84.58 
Prev. Close
83.845 
1-M High
85.39 
Volume 
75.10K 
Bid
70.81
Ask
110
Day Low
83.15 
Open
84.4 
1-M Low
80.04 
Market Cap 
1.89B 
Currency USD 
P/E 42.56 
%Yield 0.85 
10-SMA 83.17 
20-SMA 82.88 
50-SMA 83.72 
52-W High 109.58 
52-W Low 71.42 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.97/2.47
Enterprise Value
2.08B
Balance Sheet
Book Value Per Share
15.38
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
219.86M
Operating Revenue Per Share
8.21
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed：2025/07/06 06:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.